Meningococcal serogroup B vaccination series initiation in the United States: A real-world claims data analysis

• Auteurs principaux: Elizabeth R. Packnett (Auteur), Nicole M. Zimmerman (Auteur), Patricia Novy (Auteur), Laura C. Morgan (Auteur), Nnenna Chime (Auteur), Parinaz Ghaswalla (Auteur)
• Format: Livre
• Publié: Taylor & Francis Group, 2023-01-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

In the United States (US), meningococcal serogroup B (MenB) vaccination has been recommended for 16-23-year-olds (preferably 16-18 years) based on shared clinical decision-making since 2015. MenB vaccine coverage (≥1 dose) by age 17 years has been reported, but initiation at older ages and by insura...